CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2016	Jun. 30, 2015	Jun. 30, 2016	Jun. 30, 2015	Dec. 31, 2015
Cash flows from operating activities
Net loss	$ (42,660)	$ (445,195)	$ (1,446,071)	$ (17,411,650)
Adjustments to reconcile net income to cash used in operating activities, net of acquisitions
Stock based compensation expense			256,164	176,426
Depreciation and amortization			4,460,895	3,118,296
Rent paid by common stock			244,000	0
Gain on sale of assets	0	(12,818)	(9,748,561)	0
Loss on sale of assets			46,728	63,410
Increase in fair value of derivative liability	(1,645,288)	(1,816,982)	341,032	(1,816,982)
Deferred federal income tax expense/(gain)			0	5,306,000	$ 5,306,000
Changes in operating assets and liabilities
Accounts receivable			(1,047,149)	(3,096,566)
Allowance for doubtful accounts			0	2,650,000
Inventory			(224,462)	3,532,326
Prepaid expenses			230,614	(327,343)
Costs in excess of billings			0	779,285
Accounts payable and accrued expenses			(4,664,798)	(640,352)
Deferred revenue			(91,746)	61,713
Other assets			(1,303)	0
Net cash used in operating activities			(11,644,657)	(7,605,437)
Cash flows from investing activities
Purchase of fixed assets			(2,310,582)	(1,196,240)
Proceeds from sale of Bango assets			29,788,114	0
Costs related to sale of Bango assets			(10,792,446)	0
Establish escrow account - restricted cash			(1,501,792)	0
Notes receivable			0	(500,000)
Proceeds from sale of Bango assets			20,900	4,500
Net cash provided by (used in) investing activities			15,204,194	(1,691,740)
Cash flows from financing activities
Proceeds from sale of Series C Preferred stock			4,000,000	0
Payments for Repurchase of Convertible Preferred Stock			(11,189,849)	0
Payments of Stock Issuance Costs			(607,890)	0
Proceeds from note payable			5,405,091	0
Payments on note payable			(17,753,076)	(16,375,703)
Line of credit (payments) proceeds, net			444,698	1,815,795
Net cash provided by (used in) financing activities			(351,270)	8,997,644
Net change in cash and cash equivalents			3,208,267	(299,533)
Cash and cash equivalents at beginning of the period			765,364	6,017,076	6,017,076
Cash and cash equivalents at end of period	3,973,631	5,717,543	3,973,631	5,717,543	765,364
SUPPLEMENTAL INFORMATION
Cash paid for interest			1,006,379	2,071,299
Cash (paid) received for income tax expense (benefit)			117,646	0
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Accretion of discount on Series B and B-1 Preferred stock	471,877	0	858,535	0
Dividends-in-Kind accrued on Series B and B-1 Preferred stock and retirement of a portion of the Series B Preferred	6,191,033	$ 0	6,191,033	0
Beneficial Conversion of Series B and B1 Preferred stock			2,371,106	5,737,810
Fair value of warrants issued with Series B and B1 Preferred stock			4,756,900	5,211,085
Series B Preferred Stock
Cash flows from financing activities
Proceeds from Issuance of Preferred Stock and Preference Stock			0	23,557,552
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Dividends-in-Kind accrued on Series B and B-1 Preferred stock and retirement of a portion of the Series B Preferred	264,074		264,074		$ 376,571
Series B1 Preferred Stock
Cash flows from financing activities
Proceeds from Issuance of Preferred Stock and Preference Stock			19,349,756	0
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Dividends-in-Kind accrued on Series B and B-1 Preferred stock and retirement of a portion of the Series B Preferred	$ 145,123		145,123
Common stock
NON-CASH INVESTING AND FINANCING TRANSACTIONS
Conversion of Series A Preferred Stock into common stock			$ 120	$ 17